stocktools
Offerings // bioAffinity Technologies, Inc.

BIAFW offering history

Every offering-related filing in bioAffinity Technologies, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 372 filings back to Jul 26, 2017.

Last executed offering
Jun 18, 2026
424B4 — priced deal (shares or notes)
Last registration (announced)
Jun 16, 2026
S-1/A — capacity, not a sale
Executed, last 12 months
4
424B pricings + 8-K 3.02 sales
Registered, last 12 months
7
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 18, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 16, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 16, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 12, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 14, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 12, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 30, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 9, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 30, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 25, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Sep 24, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Sep 18, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 16, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 15, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Aug 29, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Aug 14, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 3, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 3, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 27, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 7, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
May 5, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
May 5, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 2, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 22, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 18, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 11, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 27, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 25, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 25, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 9, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 6, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 27, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Nov 22, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 22, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 22, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 21, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 21, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 23, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 19, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
BIAFW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BIAFW workspace →
BIAFW offering FAQ

When did BIAFW last execute an offering?

Per SEC filings, bioAffinity Technologies, Inc.'s most recent priced offering document is a 424B4 filed 2026-06-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BIAFW last announce or register an offering?

The most recent registration is a S-1/A filed 2026-06-16. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.